Albuminuria Lowering Effect of Dapagliflozin, Spironolactone and Their Combination in Adult Patients With Alport Syndrome (COMBINE-ALPORT)

Clinical trial NCT06499948 · COMPLETED

Trial details

NCT number: NCT06499948
Sponsor: Stefan Lujinschi
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Alport Syndrome Thin Basement Membrane Disease Alport Nephropathy

Start date: 2024-02-26
Primary completion: 2025-11-21
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.